Your session is about to expire
← Back to Search
Lipiflow treatment results for Meibomian Gland Dysfunction (Reduce Trial)
N/A
Waitlist Available
Research Sponsored by Dunes Eye Consultants
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
Purpose: To evaluate the efficacy of vectored thermal pulsation treatment in subjects with a history of dry eye disease currently using a topical immunomodulator medication.
Eligible Conditions
- Meibomian Gland Dysfunction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Subjects discontinuing Topical Immunomodulator use
Trial Design
1Treatment groups
Experimental Treatment
Group I: Lipiflow treatment resultsExperimental Treatment1 Intervention
A single thermal vectored pulsation treatment of MGD with 3 month results review of treatment to evaluate objective and subjective response.
Find a Location
Who is running the clinical trial?
Johnson & JohnsonIndustry Sponsor
109 Previous Clinical Trials
163,333 Total Patients Enrolled
Dunes Eye ConsultantsLead Sponsor
Share this study with friends
Copy Link
Messenger